Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A comparison of international management guidelines for atopic dermatitis
Lindsey M. LePoidevin, Dylan E. Lee, Vivian Y. Shi
Pediatric Dermatology (2018) Vol. 36, Iss. 1, pp. 36-65
Open Access | Times Cited: 55

Showing 1-25 of 55 citing articles:

Atopic Dermatitis
Sonja Ständer
New England Journal of Medicine (2021) Vol. 384, Iss. 12, pp. 1136-1143
Closed Access | Times Cited: 458
New and Upcoming Topical Treatments for Atopic Dermatitis: A Review of the Literature
Nikolaos Sideris, Eleni Paschou, K. Bakirtzi, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 17, pp. 4974-4974
Open Access | Times Cited: 39
Mast Cells Initiate Type 2 Inflammation through Tryptase Released by MRGPRX2/MRGPRB2 Activation in Atopic Dermatitis
Tao Jia, Delu Che, Yi Zheng, et al.
Journal of Investigative Dermatology (2023) Vol. 144, Iss. 1, pp. 53-62.e2
Closed Access | Times Cited: 22
Real‐world clinical, psychosocial and economic burden of atopic dermatitis: Results from a multicountry study
Kilian Eyerich, Melinda Gooderham, Juan Francisco Silvestre, et al.
Journal of the European Academy of Dermatology and Venereology (2023) Vol. 38, Iss. 2, pp. 340-353
Open Access | Times Cited: 20
Global epidemiology and disparities in atopic dermatitis
Anisa Mosam, Gail Todd
British Journal of Dermatology (2023) Vol. 188, Iss. 6, pp. 726-737
Closed Access | Times Cited: 16
Aryl hydrocarbon receptor/nuclear factor E2‐related factor 2 (AHR/NRF2) signalling: A novel therapeutic target for atopic dermatitis
Jonwei Hwang, Edita M. Newton, Jennifer L. Hsiao, et al.
Experimental Dermatology (2022) Vol. 31, Iss. 4, pp. 485-497
Open Access | Times Cited: 26
The European TREatment of ATopic eczema (TREAT) Registry Taskforce survey: prescribing practices in Europe for phototherapy and systemic therapy in adult patients with moderate‐to‐severe atopic eczema*
F.M. Vermeulen, Louise A. A. Gerbens, Jochen Schmitt, et al.
British Journal of Dermatology (2020) Vol. 183, Iss. 6, pp. 1073-1082
Open Access | Times Cited: 33
Efficacy of Nonprescription Moisturizers for Atopic Dermatitis: An Updated Review of Clinical Evidence
Adelaide A. Hebert, Frank Rippke, Teresa M. Weber, et al.
American Journal of Clinical Dermatology (2020) Vol. 21, Iss. 5, pp. 641-655
Open Access | Times Cited: 33
Updated understanding ofStaphylococcus aureusin atopic dermatitis: From virulence factors to commensals and clonal complexes
Jonwei Hwang, Alyssa M. Thompson, Joanna Jaros, et al.
Experimental Dermatology (2021) Vol. 30, Iss. 10, pp. 1532-1545
Open Access | Times Cited: 30
Dupilumab in Adults with Moderate-to-Severe Atopic Dermatitis and Prior Use of Systemic Non-Steroidal Immunosuppressants: Analysis of Four Phase 3 Trials
C.E.M. Griffiths, Marjolein de Bruin‐Weller, Mette Deleuran, et al.
Dermatology and Therapy (2021) Vol. 11, Iss. 4, pp. 1357-1372
Open Access | Times Cited: 26
A clinician’s reference guide for the management of atopic dermatitis in Asians
Steven Chow, Chew Swee Seow, Maria Victoria Dizon, et al.
Asia Pacific Allergy (2018) Vol. 8, Iss. 4, pp. e41-e41
Open Access | Times Cited: 29
Taiwan guidelines for the diagnosis and management of pediatric atopic dermatitis: Consensus statement of the Taiwan Academy of Pediatric Allergy, Asthma and Immunology
Tsung‐Chieh Yao, I‐Jen Wang, Hai‐Lun Sun, et al.
Journal of Microbiology Immunology and Infection (2022) Vol. 55, Iss. 4, pp. 561-572
Open Access | Times Cited: 14
Managing atopic dermatitis with systemic therapies in adults and adolescents: An Australian/New Zealand narrative
Marius Rademaker, Karen Agnew, Megan Andrews, et al.
Australasian Journal of Dermatology (2019) Vol. 61, Iss. 1, pp. 9-22
Open Access | Times Cited: 16
Model-Based Meta-Analysis to Optimize Staphylococcus aureus‒Targeted Therapies for Atopic Dermatitis
Takuya Miyano, Alan D. Irvine, Reiko Tanaka
JID Innovations (2022) Vol. 2, Iss. 3, pp. 100110-100110
Open Access | Times Cited: 9
Approach to the Assessment and Management of Pediatric Patients With Atopic Dermatitis: A Consensus Document. Section III: Treatment Options for Pediatric Atopic Dermatitis
Perla Lansang, Joseph M. Lam, Danielle Marcoux, et al.
Journal of Cutaneous Medicine and Surgery (2019) Vol. 23, Iss. 5_suppl, pp. 19S-31S
Open Access | Times Cited: 14
Effectiveness and Safety of Herbal Medicine for Atopic Dermatitis: An Overview of Systematic Reviews
Chan‐Young Kwon, Boram Lee, Suran Kim, et al.
Evidence-based Complementary and Alternative Medicine (2020) Vol. 2020, Iss. 1
Open Access | Times Cited: 14
Use of systemic therapies in adults with atopic dermatitis: 12-month results from the European prospective observational study in patients eligible for systemic therapy for atopic dermatitis (EUROSTAD)
Marjolein de Bruin‐Weller, Andrew Pink, Silvia Ferrucci, et al.
Journal of Dermatological Treatment (2022) Vol. 33, Iss. 5, pp. 2565-2570
Open Access | Times Cited: 8
Emerging Systemic Therapeutic Biologics and Small Molecules for Atopic Dermatitis: How to Decide Which Treatment Is Right for Your Patients
Jiyoung Ahn, Erin E. Grinich, Yu Sung Choi, et al.
The Journal of Allergy and Clinical Immunology In Practice (2021) Vol. 9, Iss. 4, pp. 1449-1460
Closed Access | Times Cited: 11
Efficacy and safety of abrocitinib for the treatment of moderate-to-severe atopic dermatitis: a meta-analysis of randomized clinical trials
Bikash Ranjan Meher, Rashmi Ranjan Mohanty, Biswa Mohan Padhy
Journal of Dermatological Treatment (2021) Vol. 33, Iss. 4, pp. 2335-2343
Closed Access | Times Cited: 10
Pioneering global best practices in atopic dermatitis: results from the atopic dermatitis quality of care initiative
Emma Guttman‐Yassky, Audrey Nosbaum, Eric L. Simpson, et al.
Clinical and Experimental Dermatology (2021) Vol. 47, Iss. 2, pp. 303-311
Closed Access | Times Cited: 10
Use of Dexpanthenol for Atopic Dermatitis—Benefits and Recommendations Based on Current Evidence
Yoon Sun Cho, Hye One Kim, Seung Man Woo, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 14, pp. 3943-3943
Open Access | Times Cited: 6
Associations Between Shower and Moisturizing Practices with Atopic Dermatitis Severity: A Prospective Longitudinal Cohort Study
Uros Rakita, Trisha Kaundinya, Jonathan I. Silverberg
Dermatitis (2023) Vol. 34, Iss. 5, pp. 425-431
Closed Access | Times Cited: 3
Burden, Control, and Treatment of Moderate to Severe Atopic Dermatitis in 2021: A United States Patient Survey Study
Peter Lio, deMauri Mackie, Dawn Bates, et al.
Journal of Drugs in Dermatology (2023) Vol. 22, Iss. 2, pp. 119-131
Open Access | Times Cited: 3
Synthesis and self-assembling of hyaluronan grafted with ceramide NP for topical drug delivery
Martin Juhaščik, Kateřina Kopecká Štarmanová, Martina Brandejsová, et al.
Carbohydrate Polymers (2023) Vol. 321, pp. 121283-121283
Closed Access | Times Cited: 3
Comparison of lotions, creams, gels and ointments for the treatment of childhood eczema: the BEE RCT
Matthew J Ridd, Sian Wells, Stephanie MacNeill, et al.
Health Technology Assessment (2023), pp. 1-120
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top